Bloomios Inc
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to… Read more
Bloomios Inc (BLMS) - Total Assets
Latest total assets as of September 2023: $1.93 Million USD
Based on the latest financial reports, Bloomios Inc (BLMS) holds total assets worth $1.93 Million USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bloomios Inc - Total Assets Trend (2002–2022)
This chart illustrates how Bloomios Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bloomios Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Bloomios Inc's total assets of $1.93 Million consist of 9.4% current assets and 90.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | -0.2% |
| Accounts Receivable | $526.17K | 2.0% |
| Inventory | $1.77 Million | 6.8% |
| Property, Plant & Equipment | $1.58 Million | 6.1% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $21.87 Million | 84.1% |
Asset Composition Trend (2002–2022)
This chart illustrates how Bloomios Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bloomios Inc's current assets represent 9.4% of total assets in 2022, a decrease from 100.0% in 2002.
- Cash Position: Cash and equivalents constituted -0.2% of total assets in 2022, down from 73.0% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 84.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 84.1% of total assets.
Bloomios Inc Competitors by Total Assets
Key competitors of Bloomios Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Bloomios Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bloomios Inc generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bloomios Inc is currently not profitable relative to its asset base.
Bloomios Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.06 | 0.00 |
| Quick Ratio | 0.00 | 0.02 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-32.78 Million | $ -7.61 Million | $ -689.84K |
Bloomios Inc - Advanced Valuation Insights
This section examines the relationship between Bloomios Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 549.1% |
| Total Assets | $26.01 Million |
| Market Capitalization | $4.22K USD |
Valuation Analysis
Below Book Valuation: The market values Bloomios Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bloomios Inc's assets grew by 549.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bloomios Inc (2002–2022)
The table below shows the annual total assets of Bloomios Inc from 2002 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $26.01 Million | +549.06% |
| 2021-12-31 | $4.01 Million | +25.48% |
| 2020-12-31 | $3.19 Million | +305513.11% |
| 2019-12-31 | $1.04K | -- |
| 2018-12-31 | $0.00 | -- |
| 2006-12-31 | $10.44K | +97.69% |
| 2005-12-31 | $5.28K | -78.80% |
| 2004-12-31 | $24.92K | +304.13% |
| 2003-12-31 | $6.17K | -53.95% |
| 2002-12-31 | $13.39K | -- |